Can we give pantoprazole (proton pump inhibitor) to a child with abdominal pain suspected of having gastroesophageal reflux disease (GERD) or peptic ulcer disease (PUD)?

Can Pantoprazole Be Given to a Child with Suspected GERD or PUD?

Pantoprazole can be given to children aged 5 years and older with endoscopically-confirmed erosive esophagitis (EE) associated with GERD, but it should NOT be used for symptomatic GERD without endoscopic confirmation, and it is NOT indicated for infants under 1 year of age. 1

Age-Specific Recommendations

Children 5-16 Years Old

• Pantoprazole is FDA-approved for short-term treatment (up to 8 weeks) of erosive esophagitis associated with GERD in children 5 years and older 1
• The indication requires endoscopically-confirmed EE (Hetzel-Dent score ≥ 2), not just symptoms of reflux 1
• Dosing: 20 mg or 40 mg once daily, with both doses showing significant symptom reduction as early as 1 week in children aged 5-11 years 2

Children 1-5 Years Old

• While clinical trial data support efficacy for EE in this age group (all 4 patients with confirmed EE healed at 8 weeks), there is no commercially available age-appropriate dosage formulation 1
• Therefore, pantoprazole is not practically indicated for children under 5 years despite some evidence of effectiveness 1

Infants Under 1 Year

• Pantoprazole is NOT effective and NOT indicated in infants under 1 year of age 1
• A randomized, placebo-controlled trial of 129 infants (1-11 months) showed no statistically significant difference between pantoprazole and placebo for symptomatic GERD 1
• Adverse events were more common with pantoprazole, including elevated CK, otitis media, rhinitis, and laryngitis 1

Critical Clinical Decision Points

When Pantoprazole Should NOT Be Used

1. Symptomatic GERD Without Endoscopic Confirmation

• The effectiveness of pantoprazole for treating symptomatic GERD in pediatric patients has not been established 1
• Pediatric trials were inconclusive regarding clinical benefit for symptomatic GERD without confirmed esophagitis 1

2. Chronic Cough Without GER Symptoms

• Treatment for GERD should NOT be used when there are no clinical features of GERD such as recurrent regurgitation, dystonic neck posturing (infants), or heartburn/epigastric pain (older children) 3
• Acid suppressive therapy should not be used solely for chronic cough 3

3. First-Line Therapy

• Lifestyle modifications should be attempted first before considering pharmacologic therapy 3, 4
• For breastfed infants: 2-4 week trial of maternal exclusion diet (restricting milk and eggs) 3
• For formula-fed infants: trial of extensively hydrolyzed protein or amino acid-based formula 3

When to Consider Endoscopy Before Treatment

Endoscopy with esophageal biopsy is indicated when: 3

• Failure to respond to pharmacologic therapy
• Poor weight gain
• Unexplained anemia or fecal occult blood
• Recurrent pneumonia
• Hematemesis

Important caveat: Children with typical GERD symptoms refractory to PPI treatment should undergo endoscopy to exclude eosinophilic esophagitis 3

Safety Concerns in Pediatric Populations

Short-Term Risks

• Increased risk of lower respiratory tract infections, particularly in infants 5
• Community-acquired pneumonia, gastroenteritis, and candidemia 3, 4

Long-Term Risks (>2.5 years)

• Enterochromaffin cell hyperplasia in up to 50% of children 5
• Vitamin B12 deficiency 5
• Bone fractures 5

Bone Development Concerns

• Animal studies showed decreased femur length, weight, and changes in bone mass/geometry at doses producing similar exposures to pediatric therapeutic doses 1
• Changes were partially reversible after discontinuation 1

Alternative Approaches

If Pantoprazole Cannot Be Used

• Omeprazole (0.7-3.3 mg/kg/day) is FDA-approved for children 2-16 years and has been shown more effective than H2-receptor antagonists 5, 4
• Esomeprazole (10-20 mg once daily based on weight) is another FDA-approved alternative 5

Treatment Duration

• PPIs should be administered approximately 30 minutes before meals for optimal effect 5, 4
• Treatment should be limited to 8-12 weeks initially, with re-evaluation if symptoms remain refractory 5
• PPIs and H2 receptor antagonists should not be used longer than 4-8 weeks without further evaluation 3

Common Pitfalls to Avoid

1. Do not use pantoprazole empirically for abdominal pain without clear GERD symptoms or endoscopic confirmation 3, 1
2. Do not prescribe for infants under 1 year - it is ineffective and potentially harmful 1
3. Do not continue beyond 8 weeks without endoscopic re-evaluation or specialist consultation 5
4. Do not forget to withdraw PPIs for at least 3 weeks before endoscopy if eosinophilic esophagitis is being considered 3
5. Do not overlook milk protein allergy as a mimic of GERD, especially in infants 3